XML 19 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net loss $ (5,831,779) $ (3,736,878)
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 3,554,322 3,488,398
Impairment of monitoring equipment and parts 180,000 225,522
Bad debt expense 844,968 347,488
Common stock issued for services 60,001 217,085
Amortization of debt discount 167,230 286,751
Loss on disposal of monitoring equipment included on cost of sales 67,097 184,556
Stock based compensation 539,275 0
Vesting and re-pricing of stock options 437,197 341,905
Loss on disposal of property and equipment 27,419 (334,981)
Change in assets and liabilities:    
Accounts receivable, net (1,430,852) (2,857,986)
Notes receivable (28,299) (23,755)
Inventories 161,159 (746,822)
Prepaid expenses and other assets 581,451 (686,759)
Accounts payable 145,774 1,419,089
Accrued expenses 2,489,900 1,054,190
Deferred revenue 0 (6,881)
Net cash provided by (used in) operating activities 1,964,863 (829,078)
Cash flow from investing activities:    
Purchase of property and equipment (58,271) (482,343)
Capitalized software (1,518,800) 0
Purchase of monitoring equipment and parts (2,315,140) (1,625,853)
Leasehold improvements 0 (28,662)
Payment related to acquisition 0 (1,782,849)
Net cash used in investing activities (3,892,211) (3,919,707)
Cash flow from financing activities:    
Principal payments on notes payable (1,003,976) (1,768,282)
Repurchase of Series D Convertible Preferred Stock and warrants 0 (10,500)
Net cash used in financing activities (1,003,976) (1,778,782)
Effect of exchange rate changes on cash 36,131 (50,787)
Net decrease in cash (2,895,193) (6,578,354)
Cash, beginning of period 4,903,045 11,101,822
Cash, end of period 2,007,852 4,523,468
Cash paid for interest 50,614 933,808
Supplemental schedule of non-cash investing and financing activities:    
Issuance of warrants for accrued Board of Director fees 133,135 270,016
Payment of interest from an increase in interest bearing debt 1,399,644 0
Common stock issuance for the acquisition of a subsidiary and milestone achievement $ 61,432 $ 912,404